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Introduction
Langerhans cell histiocytosis (LCH) is a clonal
proliferative disorder of Langerhans cells [1]. Three
disease variants are included in this description:
unifocal disease (solitary eosinophilic granuloma),
multi-focal unisystem disease (including cases of
Hand-Schuller-Christian syndrome), and multi-focal
multi-system disease including cases of Letterer-Siwe
syndrome [2, 3]. Bone is the most frequently affected
organ; the majority of patients present with solitary or
multiple bone lesions, and involvement of the jaw is
not unusual [4]. Although LCH is not considered a
malignant disease, its appearance on radiographs may
be similar to that of a malignant tumor [5]. 
The diagnosis of LCH is usually made by a soft
tissue biopsy, or by bone marrow aspiration or
curettage. If the lesion is confirmed as LCH with a
core biopsy, therapeutic surgical excision is typically
planned. For example, if the lesion is revealed to be a
malignant bone lesion, a secondary operation or
chemotherapy could be needed, while if the lesion is
benign, a therapeutic excision biopsy would be
planned. To our knowledge, few studies have
considered whether ultrasound (US)-guided core
biopsy is useful for preoperative pathologic
confirmation of LCH.
We present a patient with a mandibular mass
confirmed to be LCH by US-guided core needle
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Langerhans cell histiocytosis (LCH) is a clonal proliferative disorder of Langerhans
cells. Although LCH is not considered a malignant disease, its appearance on radi-
ographs may be similar to that of a malignant tumor. The diagnosis of LCH is usually
made by a soft tissue biopsy, or by bone marrow aspiration or curettage. We present
a patient with a mandibular mass confirmed to be LCH by US-guided core needle
biopsy, and present a strategy for diagnosing localized LCH of the bone based on the
usefulness and reliability of the percutaneous biopsy.
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biopsy, and present a strategy for diagnosing localized
LCH of the bone based on the usefulness and
reliability of the percutaneous biopsy.
Case Report
An 18-year-old girl was referred to our institution by
her general dental practitioner with a four week
history of increasing pain and swelling on the right
side of her face. The girl was otherwise healthy with
no complicating medical disorders. Upon examination,
there was a hard, tender mass that originated from the
right ramus of the mandible. All her teeth in the
quadrant were vital and non-mobile. Opening of the
mouth was slightly reduced and submandibular
lymphadenopathy was evident on her right side. The
hematological findings were nonspecific.
Contrast enhanced CT images showed an 2.3 cm-
sized expanded destructive mass, which had rim-
enhancement arising from the ramus of the right
mandible and adjacent to the lower right second
permanent molar (Fig. 1). The cortex was disrupted
and the mass extended into the soft tissues. 
A bone scan was performed and there was an
abnormal hot uptake lesion at the angle of the
mandible with no other skeletal lesions noted (Fig. 2).
This lesion was also found to be metabolically active
with 18F-FDG-PET (Fig. 3). Our presumptive
preoperative clinical diagnosis was a malignant bone
tumor including osteosarcoma. 
High resolution US imaging performed on the lesion
showed a bulging soft tissue mass originating from the
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Fig. 1. Axial CT scan shows invasive, destructive borders of the
lesion and soft tissue mass on the lateral aspect of the right
mandibular body.
Fig. 2. Whole-body scintigram shows marked radiotracer
uptake at the right mandible. There was no uptake in other
skeletal system components. 
Fig. 3. 18F-FDG-PET shows intense metabolic activities at the
right mandible.
right mandible, which had relatively heterogeneous
echogenecity with an irregular margin (Fig 4). Color
Doppler images showed slightly increased blood flow.
In addition, US-guided biopsy was performed by a
radiologist, using a 5-12 MHz machine (IU22; Phillps,
Bothell Wash) with a 14-gauge multi-fire needle (TSK
ACECUT Biopsy System,Tochigi, Japan) under local
anesthesia; 4-core specimens (needle excursion length;
2 cm) were obtained. No specific complication was
noted and the lesion was revealed to be LCH (Fig. 5).
The planned surgical excision was performed and the
diagnosis was the same. The patient has had no
evidence of active LCH during one-year of follow-up.
Discussion
LCH is a reactive disorder characterized by the
infiltration and proliferation of dendritic cells with the
appearance of normal Langerhans’ cells [6]. Osseous
involvement is the most common manifestation of
LCH, occurring in 60-95% of pediatric patients.
Solitary bone lesions are typically treated surgically,
but medical treatment is indicated for multiple or
progressive lesions or bone lesions not amenable to
excision [7]. Thus, imaging is used to identify multi-
focal disease or to give an indication of lesional
metabolic activity. Plain radiographs, CT, and bone
scintigraphy have been the traditional modalities used
in imaging. However, recent studies have found that
bone lesions with high concentrations of histiocytes
show increased metabolic activity with FDG-PET. 
The radiologic appearance of osseous LCH depends
on the site of involvement. Lesions typically appear as
‘expandable’osteolytic but may have either poorly
defined borders or well-demarcated margins, and with
or without reactive sclerosis. CT imaging is useful in
providing detailed cross-sectional anatomic details of
the involved bone. However, these findings are
nonspecific compared to the findings of other soft
tissue masses arising in the skeletal system. US
imaging is also limited for the description of a soft
tissue mass, which can just demonstrate the space-
occupying mass within bone, with or without a
cortical disruption.
Because LCH lacks pathognomonic clinical or
radiographic characteristics, a definitive diagnosis
should be based on the histologic and immuno-
histochemical study of lesional biopsy specimens.
Radiographically, the differential diagnosis includes
osteomyelitis and Ewing’s sarcoma in children and
metastatic carcinoma as well as other benign and
malignant primary tumors of bone in adults. 
These soft tissue and bone masses that cannot be
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Fig. 4. Ultrasonograms of the mandible show a soft tissue mass
arising from cortex of the mandible with cortical destruction.
Fig. 5. The core biopsy specimen shows diffuse infiltration of
Langerhans cells admixed with inflammatory cells, including
eosinophils. The diagnosis was Langerhans cell histiocytosis (H &
E, ×40).
identified by imaging studies are considered
indeterminate and a surgical or percutaneous biopsy is
usually necessary to identify them [8]. An open biopsy
has been considered as the gold standard for the initial
diagnosis of soft tissue and bone masses. While an
open biopsy can fetch a large amount of tissue,
general anaesthesia is necessary, which increases the
cost of the procedure [9]. In addition, up to 50% of
microscopic residual disease has been reported in
sarcomas when an excisional biopsy (enucleation) was
performed [10, 11]. A percutaneous core needle
biopsy is a minimally invasive, inexpensive, and
efficient diagnostic method which is increasingly used
in the initial approach to these types of tumors, with a
reported diagnostic accuracy ranging from 78% to
97% [12, 13]. Although percutaneous needle biopsy
may result in sampling errors because of the small
amounts of tissue obtained, the combination of
guidance from CT or US, reliable immuno-
histochemistry, and experienced pathologists can
show a higher sensitivity and specificity rates [13-15]. 
Image guidance is generally required for biopsies of
head and neck lesions. CT, with its high spatial and
contrast resolution, is the imaging modality of choice
for biopsies of deep-seated head and neck lesions. CT
allows excellent delineation of intervening vital
structures, which permits a safe biopsy path planning.
With CT, the operator can target the appropriate part
of the mass and avoid areas of necrosis. On the other
hand, US-guided core needle biopsy, with its inherent
advantages of real-time imaging capability, decreased
procedural time, ability to visualize vessels without
use of intravenous contrast material, portability, lack
of ionizing radiation, and decreased cost, allows for
the confirmation of the superficial-seated head and
neck lesion as LCH, and avoids unnecessary excessive
surgery. Additionally, by high-resolution US imaging
of superficial skin lesions, the anatomy can be
defined, lesions characterized, and blood flow
confirmed, all without the use of ionizing radiation [7].
In our case, US imaging of the mass on the right
mandible provided tumor characteristics, disease
extent, as well as guidance for the core biopsy.
However, US examination is limited by the inability
of sound waves to penetrate overlying bone [7].
Therefore, US-guided biopsy also could be limited by
a soft tissue mass bulging out from the bony cortex,
which would require a careful approach during the
progression of the needle tip. Major complications
from image-guided core biopsies are rare. Minor
complications include pain, vasovagal reaction, minor
infection and bleeding. 
In summary, our observation suggests that a US-
guided core biopsy for LCH as a solitary bony mass
provides an accurate histologic confirmation and
optimal guidelines for a treatment plan.
요 약
랑거한스세포 조직구증 (Langerhans cell histiocyto-
sis, LCH)는 랑거한스세포의 이상 증식을 특징으로 하는
원인 불명의 질환이다. LCH가 악성질환으로 간주되지는
않으나, 영상의학적 형태는 악성종양의 그것과 유사할 수
있다. LCH의 진단은 대부분 연부조직 생검, 골수 흡입생
검 또는 소파술로 이루어진다. 우리는 초음파 유도하 조직
생검을 통해 LCH로 진단된 하악종괴를 가진 환자에 대한
1예를 보고하고, 골부에 국한된 LCH를 진단할 수 있는 경
피 조직검사의 유용성과 안정성을 보여주고자 한다.
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